These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 904803

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Treatment of advanced or recurrent endometrial adenocarcinoma with cyclophosphamide, doxorubicin, cis-Platinum, and megestrol acetate.
    Lovecchio JL, Averette HE, Lichtinger M, Townsend PA, Girtanner RW, Fenton AN.
    Obstet Gynecol; 1984 Apr; 63(4):557-60. PubMed ID: 6538327
    [Abstract] [Full Text] [Related]

  • 23. [Therapy of adenocarcinoma of the endometrium with synthetic progestogens].
    Lanza A, Fedele M, Renzetti ME, Ferraris G.
    Minerva Ginecol; 1981 Oct; 33(10):917-36. PubMed ID: 7031519
    [No Abstract] [Full Text] [Related]

  • 24. [Oral high doses of medroxyprogesterone acetate (MPA) in the treatment of advanced phases of breast and endometrial cancer].
    Bernardo-Strada MR, Imparato E, Aspesi G, Pavesi L, Robustelli Della Cuna G.
    Minerva Med; 1980 Nov 10; 71(44):3241-6. PubMed ID: 7454090
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Adjuvant gestagen therapy in stage I endometrial cancer].
    Lahousen M, Pickel H.
    Zentralbl Gynakol; 1988 Nov 10; 110(16):1013-7. PubMed ID: 2973195
    [Abstract] [Full Text] [Related]

  • 27. Rating the Chemotherapy Options for Advanced Uterine Adenocarcinoma.
    Look KY.
    Medscape Womens Health; 1996 Dec 10; 1(12):2. PubMed ID: 9746660
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [MAP in the therapy of adenocarcionoma of the endometrium. Immediate clinical results and general endocrine effects].
    Ricciardi I, Calì A, Imparato E, Marino L, Pesando P.
    Minerva Ginecol; 1975 Sep 10; 27(9):744-53. PubMed ID: 1207966
    [No Abstract] [Full Text] [Related]

  • 31. Evaluation of the mechanism of action of a progestin on endometrial andenocarcinoma.
    Anderson DG.
    Surg Forum; 1969 Sep 10; 20():411-3. PubMed ID: 5376941
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Nonhormonal chemotherapy in endometrial cancer--a review.
    Deppe G, Malviya VK, Zbella E.
    Wien Klin Wochenschr; 1984 Oct 26; 96(20):747-56. PubMed ID: 6441352
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Action of MAP in adenocarcinoma of the endometrium. Clinical results and ultrastructural and histochemical study].
    Pullè C, Rigano A.
    Minerva Ginecol; 1981 Oct 26; 33(10):937-54. PubMed ID: 7031520
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.